2021 IPO

PROCEPT BioRobotics Stock

Medical device company

Sign up today and learn more about PROCEPT BioRobotics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

Perceptive Advisors


Redwood Shores CA, US

Total Funding


About PROCEPT BioRobotics Stock

PROCEPT BioRobotics is a clinical-stage medical device company based in Silicon Valley. The Company has developed a disruptive surgical product for transurethral resection of prostate tissue – The AquaBeam® – and other treatment and diagnostic applications. The AquaBeam is a personalized image-guided tissue removal system, which utilizes proprietary heat-free high-velocity waterjet technology to resect and remove a predetermined volume of tissue with precise and automated incisions conforming to the shape of the prostate.


Funding History

October 2013$6.0M
August 2014$2.0M
July 2015$7.7M
July 2015$42.0M
June 2017$25.0M
February 2018$118M


Co-Founder & Chief Executive Officer

Nikolai Aljuri

Chief Financial Officer

Kevin Waters


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: